Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Management Team
    • Board of Directors
  • Scorpius Biomanufacturing
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 28, 2017 4:01pm EDT

Heat Biologics Closes Public Offering of 5,000,000 Shares of Common Stock

Mar 23, 2017 8:00am EDT

Heat Biologics Prices Offering of 5,000,000 Shares of Common Stock

Mar 22, 2017 4:04pm EDT

Heat Biologics Announces Proposed Public Offering of Common Stock

Mar 21, 2017 7:00am EDT

Heat Biologics Reports Positive Interim Phase 2 Lung Cancer Results in Patients Treated with HS-110 in Combination with a Checkpoint Inhibitor

Mar 20, 2017 7:00am EDT

Heat Biologics, Inc. to Present at The MicroCap Conference on April 4th in New York City

Mar 16, 2017 7:02am EDT

Florida Department of Health Awards Three-Year Grant to Develop gp96-based Zika Vaccine

Mar 13, 2017 7:00am EDT

Heat Biologics Meets Efficacy Endpoint in its Phase 1b Lung Cancer Trial to Progress to Phase 2

Mar 09, 2017 8:00am EST

Heat Biologics to Present at 29th Annual ROTH Conference

Mar 08, 2017 7:00am EST

Heat Biologics Announces Agreement to Acquire Pelican Therapeutics

Mar 02, 2017 8:00am EST

Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences
  • Email Alerts
  • Contacts
  • RSS News Feed
©2024 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.